ArticleCancer science2015

Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.

Yuki Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.